P5010: Cordis Palmaz XL Transhepatic Biliary Stent 10mm x 49mm

Sign in to add this product to your favorites!
| Price: | $999.00 per box of 1 |
|---|---|
| Quantity: | |
| In Stock: | 2 box of 1 |
| Expiration: | 07-2027 |
| Express: | Need it tomorrow? Order in next 1 hours 56 minutes and choose overnight shipping at checkout. |
Additional Details
Cordis Palmaz XL Transhepatic Biliary Stent (Unmounted)
- Type: Closed Cell
- Material: 316L Stainless Steel
- Stent Diameters (Expanded): 10mm
- Stent Lenghts (Unexpanded): 30mm, 40mm, 50mm
- Recommended PTA Dilatation Catheter: PowerFlex Plus Catheters
- Sheath Introducer: 10F
- Contains 1 Stent and 1 Crimping Tube
AccessGUDID Info
- FDA Product Code: FGE
- FDA Product Code Name: CATHETER, BILIARY, DIAGNOSTIC
- GMDN Term Code: 43691
- GMDN Term Name: Bare-metal biliary stent
- GMDN Term Description: A non-bioabsorbable tubular device intended to be implanted in an obstructed biliary duct (e.g., common bile duct) to maintain luminal patency; it is not intended for vascular implantation. It may be a mesh structure or a continuous tube and is made entirely of metal [e.g., high-grade stainless steel, cobalt-chrome (Co-Cr), nickel-titanium alloy (Nitinol)]. It may be expandable in situ (e.g., with a balloon catheter or self-expands) and disposable devices intended to assist implantation may be included.
Manufacturer
Cordis is a global leader in interventional cardiovascular technologies, with a strong legacy in developing minimally invasive solutions for the treatment of coronary and peripheral vascular disease. Their portfolio includes diagnostic and interventional catheters, guidewires, and balloon angioplasty systems, as well as stents like the SMART Control and S.M.A.R.T. Flex for peripheral use. Cordis also offers radial access products and closure devices to support efficient and safe procedures. With a renewed focus on innovation and global expansion, Cordis continues to provide trusted tools that help physicians deliver effective, streamlined care in both coronary and endovascular interventions.
IN-DATE